The role of biofilms in otolaryngologic infections

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 3, 2004, Pages 185-190

  Post, J Christopher ^a,b   Stoodley, Paul ^a   Hall Stoodley, Luanne ^a   Ehrlich, Garth D ^a,c  

^a ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Biofilms; Cholesteatoma; Otitis media; Otolaryngology; Tonsillitis

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIOPLANKTON; BIOFILM; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; CHRONIC TONSILLITIS; DEVICE INFECTION; HEAD AND NECK INFECTION; HOST RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

BACTERIAL INFECTIONS; BIOFILMS; CHOLESTEATOMA, MIDDLE EAR; CHRONIC DISEASE; DRUG RESISTANCE; HUMANS; OTITIS MEDIA WITH EFFUSION; OTORHINOLARYNGOLOGIC DISEASES; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; TONSILLITIS;

EID: 2542462558     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000124936.46948.6a     Document Type: Review

References (37)

1. Costerton JW, Veeh R, Shirtliff M, et al.: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112:1466-1477. This very readable perspective on the role that biofilms play in chronic infections will be of great interest to clinicians.
2. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
3. Rasmussen B: Filamentous microfossils in a 3,235-million-year-old volcanogenic massive sulphide deposit. Nature 2000, 405:676-679.
4. Costerton JW, Lewandowski Z, Caldwell DE, et al.: Microbial biofilms. Annu Rev Microbiol 1995, 49:711-745.
5. Sauer K, Camper AK, Ehrlich GD, et al.: Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002, 184:1140-1154.
6. Whitchurch CB, Tolker-Nielsen T, Ragas PC, et al.: Extracellular DNA required for bacterial biofilm formation. Science 2002, 295:1487.
7. Hausner M, Wuertz S: High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 1999, 65:3710-3713.
8. Hall-Stoodley L, Stoodley P: Developmental regulation of microbial biofilms. Curr Opin Biotechnol 2002, 13:228-233.
9. Hall-Stoodley L, Costerton JW, Stoodley P: Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004, 2:1-15. This is an excellent current review of the role that biofilms play in chronic infectious disease.
10. Whitchurch CB, Alm RA, Mattick JS: The alginate regulator AlgR and an associated sensor FimS are required for twitching motility in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 1996, 93:9839-9843.
11. Davies DG, Parsek MR, Pearson JP, et al.: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280:295-298.
12. Stoodley P, Lewandowski Z, Boyle JD, et al.: The formation of migratory ripples in a mixed species bacterial biofilm growing in turbulent flow. Environ Microbiol 1999, 1:447-455.
13. Walters MC 3rd, Roe F, Bugnicourt A, et al.: Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003, 47:317-323.
14. Brown MR, Allison DG, Gilbert P: Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother 1988, 22:777-783.
15. Anwar H, Strap JL, Costerton JW: Establishment of aging biofilms: a possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother 1992, 36:1347-1351.
16. Rayner MG, Zhang Y, Gorry MC, et al.: Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA 1998, 279:296-299.
17. Marsh PD: Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis 2003, 9(suppl 1):16-22.
18. Marrie TJ, Nelligan J, Costerton JW: A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 1982, 66:1339-1341.
19. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998, 339:520-532.
20. Fowler VG Jr, Li J, Corey GR, et al.: Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997, 30:1072-1078.
21. Fux CA, Wilson S, Stoodley P: Dispersal characteristics and antimicrobial susceptibility to emboli from Staphylococcus aureus biofilms in an in-vitro catheter infection model. J Bacteriol 2003, in press.
22. Swords WE, Rubin BK: Macrolide antibiotics, bacterial populations and inflammatory airway disease. Neth J Med 2003, 61:242-248.
23. Nguyen T, Louie SG, Beringer PM, et al.: Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease. Curr Opin Pulm Med 2002, 8:521-528.
24. Yasuda H, Ajiki Y, Koga T, et al.: Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993, 37:1749-1755.
25. Yasuda H, Ajiki Y, Koga T, et al.: Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother 1994, 38:138-141.
26. Schousboe LP, Rasmussen LM, Ovesen T: Induction of mucin and adhesion molecules in middle ear mucosa. Acta Otolaryngol 2001, 121:596-601.
27. Post JC, Preston RA, Aul JJ, et al.: Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995, 273:1598-1604.
28. Post JC, Aul JJ, White GJ, et al.: PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryngol 1996, 17:106-111.
29. Aul JJ, Anderson KW, Wadowsky RM, et al.: Comparative evaluation of culture and PCR for the detection and determination of persistence of bacterial strains and DNAs in the Chinchilla laniger model of otitis media. Ann Otol Rhinol Laryngol 1998, 107:508-513.
30. Post JC: Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001, 111:2083-2094.
31. Ehrlich GD, Veeh R, Wang X, et al.: Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002, 287:1710-1715.
32. Felding JU: Middle ear gas-its composition in the normal and in the tubulated ear. Acta Otolaryngol (Stockh) 1998, 536(suppl):1-57.
33. Kiroglu F, Kaya M, Ozsahinoglu C, et al.: Changes of middle ear mucosa in secretory otitis media treated with ventilation tubes. Acta Otolaryngol (Stockh) 1990, 110:266-273.
34. Chole RA, Faddis BT: Anatomical evidence of microbial biofilms in tonsillar tissues: a possible mechanism to explain chronicity. Arch Otolaryngol Head Neck Surg 2003, 129:634-636. This paper provides evidence expanding the biofilm paradigm to chronic tonsillitis.
35. Chole RA, Faddis BT: Evidence for microbial biofilms in cholesteatomas. Arch Otolaryngol Head Neck Surg 2002, 128:1129-1133.
36. Adair CG, Gorman SP, Feron BM, et al.: Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25:1072-1076.
37. Harada T, Ishida K, Endo M, et al.: Recurrent extrusion of cochlear implant at an interval of 5 years. Otol Neurootol 2003, 24:83-85.